Nostrum Laboratories, Inc. FDA Inspection Record
Nostrum Laboratories, Inc. is an FDA-inspected facility (FEI 1518957) located in Bryan, OH, US. RegDataLab tracks 6 FDA inspections at this facility.
What FDA found at this site
- Latest inspection
- Mar 13, 2025: Voluntary Action Indicated (VAI)
- Inspections on record
- 6 (4 VAI, 2 NAI)
- Last OAI inspection
- None on record
- Warning letters
- None matched to this FEI. Many letters do not state an FEI: search warning letters by company name
- Recalls as the recalling firm
- 2, latest Jul 11, 2025
- Import refusals
- 1
Inspections and what FDA cited
| Date | Result | What FDA cited |
|---|---|---|
| Mar 13, 2025 | Voluntary Action Indicated (VAI) | Valid stability test methods (21 CFR 211.166(a)(3)) Scientifically sound laboratory controls (21 CFR 211.160(b)) |
| Jan 11, 2018 | No Action Indicated (NAI) | No citations listed |
| Mar 15, 2016 | No Action Indicated (NAI) | No citations listed |
| Jun 28, 2013 | Voluntary Action Indicated (VAI) | Equipment Design, Size and Location (21 CFR 211.63) Written procedures not established/followed (21 CFR 211.67(b)) Equipment for Environmental Control (21 CFR 211.46(b)) Establishment of calibration procedures (21 CFR 211.160(b)(4)) |
| Jul 21, 2011 | Voluntary Action Indicated (VAI) | No citations listed |
| Jul 16, 2010 | Voluntary Action Indicated (VAI) | No citations listed |
Recalls
| Date | Class | Recall | Product and reason |
|---|---|---|---|
| Jul 11, 2025 | Class II | D-0547-2025 | Sucralfate Tablets, USP 1 gram, packaged in a) 100-count bottles NDC 29033-0003-01, and b)… CGMP Deviations: The recalling firm filed for Chapter 11 in September 2024. As a result, it cannot monitor the quality program and hence… |
| May 23, 2016 | Class II | D-1030-2016 | Nitrofurantoin Oral Suspension, USP, 25 mg/5 mL, FOR ORAL USE ONLY, URINARY TRACT… Failed Dissolution Specifications |
FDA record score
10 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.
6 records behind this number
| Record | Date | Points x age weight | Adds |
|---|---|---|---|
| Inspection classified VAI | Mar 13, 2025 | 6 x 1 | 6 |
| Class II recall D-0547-2025, this FEI as the recalling firm | Jul 11, 2025 | 4 x 1 | 4 |
| Class II recall D-1030-2016, this FEI as the recalling firm | May 23, 2016 | 10 years or older, so it adds no points | 0 |
| Inspection classified VAI | Jun 28, 2013 | 10 years or older, so it adds no points | 0 |
| Inspection classified VAI | Jul 21, 2011 | 10 years or older, so it adds no points | 0 |
| Inspection classified VAI | Jul 16, 2010 | 10 years or older, so it adds no points | 0 |
When each source was last refreshed
| Records | Last refreshed | Source as of | Status |
|---|---|---|---|
| Inspections | Nov 14, 2026 | Newest record Nov 5, 2026 | Current |
| Inspection citations | Nov 14, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions (warning letters, injunctions and other action types) | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
| Warning letter text | Nov 14, 2026 | Newest record Nov 10, 2026 | Current |
| Recalls (Enforcement Report) | Nov 14, 2026 | Newest record Nov 11, 2026 | Current |
| Form 483s and inspection documents | Nov 13, 2026 | Newest record Nov 12, 2026 | Current |
| Import refusals | Nov 2, 2026 | Newest record Oct 22, 2026 | Current |
Reviewing Nostrum Laboratories, Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Nostrum Laboratories, Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Facility details
- Company
- Nostrum Laboratories, Inc.
- Location
- Bryan, OH (US)
- Source
- inspections